MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer - Quiz - MDSpire

MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer

  • By

  • Jiali Zhang

  • Feng Tian

  • Yue Shang

  • Honghai Dai

  • Shuo Zhang

  • Bing Kang

  • Jiaxiang Xin

  • Ximing Wang

  • Changqing Jing

  • Cong Sun

  • May 29, 2026

  • 0 min

Share

Original Source(s)

MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer

  • by Jiali Zhang, Feng Tian, Yue Shang, Honghai Dai, Shuo Zhang, Bing Kang, Jiaxiang Xin, Ximing Wang, Changqing Jing, Cong Sun

  • May 29, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer